Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hormone-free moisturizing cream versus estrogen vaginal cream for postmenopausal vulvovaginal atrophy
IRCT20230408057852N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of DehydraTECH-estrogen in atrophic vaginitis and vaginal atrophy (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Vulvovaginal dryness, Burning and 3 more. Started Nov 2023; status: completed.
02
Drugs
DehydraTECH-estrogen
03
Conditions
atrophic vaginitisvaginal atrophy
Beyond the preview
Go deeper on IRCT20230408057852N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230408057852N1.